Summary
Twenty-four (48%) out of a group of 50 patients treated with one to three single doses of cisplatin compound (cis-DDP), at a dosage of 60 mg/ m2 body surface, were found to have deterioration of post-treatment pure tone audiometric threshold levels. Statistical analysis of pre- and post-treatment hearing losses by means of the paired t-test, however, did not show any significant hearing loss associated with cis-DDP-toxicity, nor could hearing loss following treatment be correlated to ages of the patients, pre-treatment hearing impairments, specific frequencies, or the number of treatment courses given. In contrast, cochlear damage was studied in the guinea pig model by daily administration of high cumulative doses of cis-DDP, and was found to be dose-dependent and selectively restricted to the outer hair cells of the inner ear and corresponding nerve fibers. Hair cell degeneration was most severe in the basal turn of the cochlea, and progressed in an apical direction so that the cells in the first row were the most affected.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Aguilar-Markulis NV, Beckley S, Priore R, Mettlin C (1981) Auditory toxicity effects of long term cis-dichlorodiammineplatinum II in genitourinary cancer patients. J Surg Oncol 16:111–123
Böheim K, Spoendlin H (1985) Three year results of combined modality therapy in locally advanced, resectable squamous cell carcinoma of the head and neck. Acta Otolaryngol (Stockh), in press
Estrem SA, Babin RW, Ryu JH, Moore KC (1981) Cis-diamminedichloroplatinum(II) ototoxicity in the guinea pig. Otolaryngol Head Neck Surg 89:638–645
Fleischmann RW, Stadnicki SW, Ethier MF, Schaeppi U (1975) Ototoxicity of cis-Dichlorodiammine Platinum (II) in the guinea pig. Toxicol Appl Pharmacol 33:320–332
Hall DJ, Diasio R, Goplerud DR (1981) Cis-Platinum in gynecologic cancer. III. Toxicity. Am J Obstet Gynecol 141:309–312
Hartwig S, Petterson U, Stahle J (1983) Cis-diamminedichloroplatinum: a cytostatic with ototoxic effect. ORL 45:257–261
Hayes DM, Cvitkovic E, Golbey RB, Scheiner E, Helson L, Krakoff IH (1977) High dose cis-platinum diamminedichloride. Amelioration of renal toxicity by mannitol diuresis. Cancer 39:1372–1381
Nakai Y, Komishi K, Chang KC, Ohashi K, Morisaki N, Minowo Y, Morimoto A (1982) Ototoxicity of the anticancer drug cisplatin. An experimental study. Acta Otolaryngol (Stockh) 93:227–232
Piel IJ, Perlia CP (1975) Phase II study of cis-dichlorodiammineplatinum(II) (NSC-119875) in combinaion with cyclophosphamide (NSC-26271) in the treatment of human malignancies. Cancer Chemother Rep 59:995–999
Reddel RR, Kefford RF, Grant JM, Coates AS, Fox RM, Tattersal HN (1982) Ototoxicity in patients receiving cisplatin: importance of dose and method of drug administration. Cancer Treatm Rep 66:19–23
Sachs L (1984) Angewandte Statistik. Methoden und ihre Anwendung, 6th edn. Springer, Berlin Heidelberg New York, pp 242–244
Spoendlin H, Brun JB (1974) The block surface technique for evaluation of cochlear pathology. Arch Otolaryngol 208:145–148
Strauss M, Towfighi J, Lipton A, Lord S, Harvey HA, Brown B (1983) Cis-platinum ototoxicty: clinical experience and temporal bone histopathology. Laryngoscope 93:1554–1559
Tange RA, Vuzevski VD (1984) Changes in the stria vascularis of the guinea pig due to cis-platinum. Arch Otolaryngol 239:41–47
Tange RA, Conijin EAJG, van Zeijl LGPM (1982) The corticotoxic effects of cis-platinum in the guinea pig. Arch Otolaryngol 237:17–26
Wright CG, Schaefer SD (1982) Inner ear histopathology in patients treated with cisplatinum. Laryngoscope 92:1408–1413
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Böheim, K., Bichler, E. Cisplatin-induced ototoxicity: Audiometric findings and experimental cochlear pathology. Arch Otorhinolaryngol 242, 1–6 (1985). https://doi.org/10.1007/BF00464398
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00464398